BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 11, 2014
View Archived Issues
Full year report - 2013 was a successful year for Lundbeck
Read More
Technetium Tc 99m trofolastat accurately detects cancer in the prostate gland
Read More
Takeda Pharmaceutical advances key programs in third quarter of fiscal 2013
Read More
ARADES and ARAFOR trial data reported for ODM-201 in prostate cancer
Read More
Protalex reports data from phase Ib trial of PRTX-100 in active rheumatoid arthritis
Read More
arGEN-X begins phase Ib study of ARGX-111
Read More
GlaxoSmithKline reports discovery of selective androgen receptor modulators
Read More
First-in-human clinical evaluation of a sustained-release exenatide for the treatment of diabetes
Read More
Ganymed Pharmaceuticals begins phase I/II trial of IMAB-027 in advanced ovarian cancer
Read More
Merck & Co. discloses new HIV prodrugs
Read More
Regeneron Pharmaceuticals and Bayer HealthCare report 2-year data from VISTA-DME trial
Read More
New targeted immunotherapy compounds designed by Shanghai Birdie Biotech
Read More
EMA's Committee for Orphan Medicinal Products issues positive opinion on Arikace
Read More
Biogen Idec patent divulges novel S1P modulating agents
Read More
Merck & Co. reports development of DPP IV inhibitors for diabetes
Read More
Sarepta Therapeutics reports safety data from phase I study of AVI-7288
Read More
Study of Repros' Androxal shows sustained effect in men with secondary hypogonadism
Read More
Aduro BioTech begins phase IIb ECLIPSE trial in patients with pancreatic cancer
Read More
Audion Therapeutics and Lilly to develop hearing loss treatments
Read More
Results from preliminary safety study evaluating trebananib plus abiraterone in patients with CRPC
Read More
Gilead submits NDA for fixed-dose combination tablet for HCV infection
Read More
Lipocine begins dosing in pivotal SOAR study
Read More
Oramed submits phase IIa protocol to FDA for oral insulin capsule
Read More
Scancell's SCIB-1 receives FDA orphan drug status for metastatic melanoma
Read More